[Federal Register Volume 62, Number 219 (Thursday, November 13, 1997)]
[Notices]
[Pages 60899-60900]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-29872]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Commission of Dietary Supplement Labels: Notice of Meeting #10

agency: Office of Disease Prevention and Health Promotion, HHS.

action: Notice of meeting.

-----------------------------------------------------------------------

summary: The Department of Health and Human Services (HHS) is providing 
notice of the tenth meeting of the Commission on Dietary Supplement 
Labels.

dates: The Commission intends to hold a brief meeting on November 24, 
1997, beginning about 1:30 p.m. E.S.T., or shortly thereafter, at the 
HHS Auditorium, Hubert H. Humphrey Building, 200 Independence Avenue, 
S.W., Washington, DC 20201. The meeting is open to the public; seating 
is limited.

for further information contact: Kenneth D. Fisher, Ph.D., Executive 
Director, Commission on Dietary Supplement Labels, Office of Disease 
Prevention and Health Promotion, Room 738G, Hubert H. Humphrey 
Building, 200 Independence Ave. S.W., Washington, D.C. 20201, (202) 
690-7102.

supplementary information: Public Law 103-417, Section 12, authorized 
the establishment of a Commission on Dietary Supplement Labels whose 
seven members have been appointed by the President. The appointments to 
the Commission by the President and the establishment of the Commission 
by the

[[Page 60900]]

Secretary of Health and Human Services reflect the commitment of the 
President and the Secretary to the development of a sound and 
consistent regulatory policy on labeling of dietary supplements.
    The Commission is charged with conducting a study and providing 
recommendations for regulation of label claims and statements for 
dietary supplements, including the use of supplemental literature in 
connection with their sale and, in addition, procedures for evaluation 
of label claims. The Commission is evaluating how best to provide 
truthful, scientifically valid, and non-misleading information to 
consumers in order that they may make informed health care choices for 
themselves and their families. The Commission's report may include 
recommendations on legislation, if appropriate and necessary.
    The purpose of Meeting #10 is to announce the completion and public 
availability of the Final Report of the Commission. The meeting agenda 
will include approval of the minutes of the previous meeting and 
follow-up activities to be undertaken by the staff.
    The meeting is open to the public; however seating is limited. If 
you will require a sign language interpreter, please call Sandra 
Saunders (202) 690-7102 by 4:30 p.m. E.S.T. on November 14, 1997.

    Dated: November 5, 1997.
Susanne A. Stoiber,
Acting Deputy Assistant Secretary for Health (Disease Prevention and 
Health Promotion), U.S. Department of Health and Human Services.
[FR Doc. 97-29872 Filed 11-12-97; 8:45 am]
BILLING CODE 4160-17-M